8251 - 8275 of 9131 Results
Title
Year
-
OPENTitle: Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor impairment and cortical dysfunction, independent of protein aggregationJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: 21Start Page: 3613End Page: 3628Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddac035Best OA location URL: https://academic.oup.com/hmg/advance-article-pdf/doi/10.1093/hmg/ddac035/42548512/ddac035.pdfCitation Count: 76
-
OPENTitle: Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonismJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 395Issue #:Start Page: 115474End Page: 115474Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115474Best OA location URL: https://doi.org/10.1016/j.expneurol.2025.115474Citation Count: 0
-
OPENTitle: Machine learning for predicting cognitive decline within five years in Parkinson’s disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkersJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 7Start Page: e0304355End Page: e0304355Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0304355Best OA location URL: https://doi.org/10.1371/journal.pone.0304355Citation Count: 14
-
OPENTitle: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 9Start Page: 2631End Page: 2640Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03101-8Best OA location URL: https://www.nature.com/articles/s41591-024-03101-8.pdfCitation Count: 38
-
OPENTitle: Predicting Parkinson’s disease trajectory using clinical and functional MRI features: A reproduction and replication studyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 20Issue #: 2Start Page: e0317566End Page: e0317566Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0317566Best OA location URL: https://doi.org/10.1371/journal.pone.0317566Citation Count: 2
-
OPENTitle: Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s diseaseJournal Name: Medizinische GenetikPublisher: Walter de Gruyter GmbHVol: 34Issue #: 2Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1515/medgen-2022-2127Best OA location URL: https://www.degruyter.com/document/doi/10.1515/medgen-2022-2127/pdfCitation Count: 8
-
OPENTitle: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page: 212End Page: 212Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03702-3Best OA location URL: https://doi.org/10.1186/s12883-024-03702-3Citation Count: 7
-
OPENTitle: Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the artJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 186End Page: 186Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-024-01144-2Best OA location URL: https://doi.org/10.1038/s41746-024-01144-2Citation Count: 40
-
OPENTitle: Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB /DJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 11Issue #: 7Start Page: 1715End Page: 1731Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.52078Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.52078Citation Count: 8
-
OPENTitle: SNCA-targeted transcriptional repression therapy alleviates pathological and behavioral perturbations in a Parkinson's disease mouse modelJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 23Issue #: 5Start Page: e01049End Page: e01049Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neurot.2026.e01049Best OA location URL: https://doi.org/10.1016/j.neurot.2026.e01049Citation Count: 0
-
OPENTitle: High-Yield α-Synuclein Purification and Ionic Strength Modification Pivotal to Seed Amplification Assay Performance and ReproducibilityJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 25Issue #: 11Start Page: 5988End Page: 5988Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms25115988Best OA location URL: https://www.mdpi.com/1422-0067/25/11/5988/pdf?version=1717053953Citation Count: 7
-
OPENTitle: Identification of Parkinson’s disease PACE subtypes and repurposing treatments through integrative analyses of multimodal dataJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page: 184End Page: 184Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-024-01175-9Best OA location URL: https://www.nature.com/articles/s41746-024-01175-9.pdfCitation Count: 41
-
OPENTitle: RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s diseaseJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 52Issue #: 18Start Page: 11158End Page: 11176Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkae776Best OA location URL: https://academic.oup.com/nar/article-pdf/52/18/11158/59744497/gkae776.pdfCitation Count: 4
-
OPENTitle: Cell-type-directed design of synthetic enhancersJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 626Issue #: 7997Start Page: 212End Page: 220Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41586-023-06936-2Best OA location URL: https://www.nature.com/articles/s41586-023-06936-2_reference.pdfCitation Count: 156
-
OPENTitle: Experiences of Pacific Peoples and their ‘āiga/kāinga/kāiga/vuvale living with Parkinsons: A qualitative studyJournal Name: PLOS OnePublisher: Public Library of Science (PLoS)Vol: 21Issue #: 8Start Page: e0355989End Page: e0355989Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0355989Best OA location URL: https://doi.org/10.1371/journal.pone.0355989Citation Count: 0
-
OPENTitle: A machine learning contest enhances automated freezing of gait detection and reveals time-of-day effectsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 4853End Page: 4853Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49027-0Best OA location URL: https://www.nature.com/articles/s41467-024-49027-0.pdfCitation Count: 43
-
OPENTitle: A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s diseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page: 1431549End Page: 1431549Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2024.1431549Best OA location URL: https://public-pages-files-2025.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2024.1431549/pdfCitation Count: 3
- Parkinson’s disease in real life healthcare organization database: a medication-based algorithm2026OPENTitle: Parkinson’s disease in real life healthcare organization database: a medication-based algorithmJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 26Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-026-04840-6Best OA location URL: https://link.springer.com/content/pdf/10.1186/s12883-026-04840-6.pdfCitation Count: 0
-
OPENTitle: Longitudinal brain structure changes in Parkinson’s disease: A replication studyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 1Start Page: e0295069End Page: e0295069Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0295069Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0295069&type=printableCitation Count: 9
-
OPENTitle: Non-motor asymmetry and dopamine degeneration in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 1Start Page: fcaf002End Page: fcaf002Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf002Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcaf002/61356326/fcaf002.pdfCitation Count: 8
-
OPENTitle: Transcriptomics and weighted protein network analyses of the LRRK2 protein interactome reveal distinct molecular signatures for sporadic and LRRK2 Parkinson’s DiseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 144End Page: 144Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00761-8Best OA location URL: https://www.nature.com/articles/s41531-024-00761-8.pdfCitation Count: 7
-
OPENTitle: The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neuronsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 5206End Page: 5206Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49256-3Best OA location URL: https://doi.org/10.1038/s41467-024-49256-3Citation Count: 14
-
OPENTitle: A person-centered approach to characterizing longitudinal ambulatory impairment in Parkinson's diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page: 11509End Page: 11509Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-62179-9Best OA location URL: http://dx.doi.org/10.1038/s41598-024-62179-9Citation Count: 1
-
OPENTitle: The Utility of Olfactory Testing to Discriminate Parkinson's Disease From Diagnostic Mimics: A Systematic Review and Meta‐AnalysisJournal Name: European Journal of NeurologyPublisher: WileyVol: 33Issue #: 1Start Page: e70473End Page: e70473Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ene.70473Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.70473Citation Count: 1
- Lysosomal genes contribute to Parkinson’s disease near agriculture with high intensity pesticide use2024OPENTitle: Lysosomal genes contribute to Parkinson’s disease near agriculture with high intensity pesticide useJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 87End Page: 87Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00703-4Best OA location URL: https://www.nature.com/articles/s41531-024-00703-4.pdfCitation Count: 23